Clinical Trial Update: Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to determine the maximum tolerated dose and evaluate pharmacokinetics, safety, tolerability, and preliminary efficacy of Hocena in patients with n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Hocena

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2014-02-27